Fig. 8
From: Fatty acid metabolism related gene MECR contributes to the progression of prostate cancer
MECR was proved to promote prostate cancer progression in vivo. A immunofluorescence analysis for Ki-67 of lung metastasis tumour sections (n = 6/group); B The effects of MECR knock out on lung metastasis and the number of metastases were examined by hematoxylin–eosin staining (H&E) staining (n = 6/group); C, D Quantitative bar graph for A-B; E Overall survival analysis of mice in lung metastasis (n = 6/group). In sh-MECR group, 4 out of 6 survived in 30days. In NC group, 1 out of 6 survived in 30 days. * Each experiment was repeated at least 2 times.